Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GNA11 inhibitors(G protein subunit alpha 11 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H36N4O |
InChIKeyFBPNEGWHSIDFPH-LEOXJPRUSA-N |
CAS Registry2625582-70-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Uveal Melanoma | Preclinical | CN | 25 Mar 2021 |